24
Participants
Start Date
December 20, 2021
Primary Completion Date
November 20, 2023
Study Completion Date
November 20, 2023
Anti-Beta Interferon (PF-06823859)
IV infusion
Debreceni Egyetem Klinikai Kozpont, Debrecen
NYU Grossman School of Medicine, The Ronald O. Perelman Department of Dermatology, New York
NYU Langone Health Clinical Research Center, New York
NYU Langone Radiology - Ambulatory Care Center East 41st Street, New York
Mount Sinai Doctors Dermatology, New York
Icahn School of Medicine at Mount Sinai, New York
Center for Human Phenomic Science, Philadelphia
University of Pennsylvania, Perelman Center for Advanced Medicine (PCAM), Philadelphia
Hospital Universitario 12 de Octubre, Madrid
Mayo Clinic in Florida, Jacksonville
University of Alabama at Birmingham, Birmingham
University of Alabama at Birmingham, Department of Dermatology, Birmingham
Cleveland Clinic Foundation, Cleveland
Center for Outpatient Health, St Louis
Washington University School of Medicine, St Louis
Washington University School of Medicine, St Louis
KU Clinical and Translational Science Unit (CTSU) Rainbow, Kansas City
University of Kansas Medical Center, Kansas City
KU Clinical Research Center - Clinical and Translational Science Unit (CTSU), Fairway
Mayo Clinic, Scottsdale
Attune Health Research Inc., Beverly Hills
Brigham & Women's Hospital, Boston
Brigham and Women's Hospital - CTH, Boston
Nova Reuma Społka Partnerska, Bialystok
Centrum Medyczne Plejady, Krakow
Lead Sponsor
Pfizer
INDUSTRY